Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olanzapine for the Prevention of Postoperative Nausea and Vomiting After Laparoscopic Surgery in High-risk Patients: A Randomized Controlled Trial

NCT04718727 is registered in ClinicalTrials.gov with Amani Hassan Abdel-Wahab as lead sponsor.

NCT NCT04718727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04718727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olanzapine for the Prevention of Postoperative Nausea and Vomiting After Laparoscopic Surgery in High-risk Patients: A Randomized Controlled Trial
Lead sponsor
Amani Hassan Abdel-Wahab
Phase
Phase 1/2
Overall status
Completed
Start date
March 15, 2021
Completion date
February 1, 2023
Enrollment
132 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea